Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Targeting the immune system, not the tumor

By Andrew Powaleny  |    April 14, 2016
One of the most exciting areas of cancer research today is immuno-oncology. Immuno-oncology is based on the concept of harnessing the body’s own immune system to fight cancer, and while it’s an...   Read More

A voice for patients

By Guest Contributor  |    April 11, 2016
Dr. Michael Rosenblatt, Executive Vice President and Chief Medical Officer - Merck  I didn’t grow up thinking I wanted to become a chief medical officer (CMO), but at a young age, my love of...   Read More

America’s biopharmaceutical industry is central to diverse R&D ecosystem

By Andrew Powaleny  |    March 29, 2016
America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that supports continued medical advances for patients. This includes small and large...   Read More

Research doesn’t end on a medicine’s approval

By Andrew Powaleny  |    March 16, 2016
Research is a critical part of the development of new medicines, but it doesn’t stop once the medicine is approved by the U.S. Food and Drug Administration (FDA).  In fact, that’s when...   Read More

Biopharmaceutical Innovation: Antibody drug conjugates

By Andrew Powaleny  |    February 29, 2016
Imagine new medicines that effectively fight cancer, but may result in fewer side effects thanks to more accurate targeting of tumor cells. Today, PhRMA released a new video that highlights these...   Read More

#pass4prostate: Tackling Prostate Cancer through Awareness, Research

By Guest Contributor  |    September 1, 2015
  Considering that 1 in 7 men will be diagnosed with prostate cancer at some point in their lives, I suspect nearly everyone reading this column has been touched by the disease – whether as a...   Read More

Biopharmaceutical Industry Strongly Committed to Responsible Clinical Trial Data Sharing to Improve Public Health

By Jeff Francer  |    July 23, 2015
The biopharmaceutical industry remains committed to enhancing public health through responsible data sharing that recognizes the importance of protecting patient privacy, respects the integrity of...   Read More

Loretta Shares a Story of Hope in the Face of Her Cancer Diagnosis

By Holly Campbell  |    May 7, 2015
When Loretta was diagnosed with Stage IV lung cancer in February 2003, she thought it was a death sentence. The news came as a shock to her and her family; she had two young children to care for...   Read More

Collaboration for Cures: Teaming Up to Advance Science and Save Lives

By Tina Stow  |    March 26, 2015
“Whether it’s our family, our friends, all of us are potentially patients one day.” In a single sentence, Dr. Anthony Coyle, senior vice president and chief scientific officer at Pfizer’s Centers...   Read More

Biopharmaceutical Sector Leads the Way in Clinical Trial Data Sharing

By Bill Chin, M.D.  |    March 15, 2015
Effective and responsible sharing of clinical trial data continues to expand scientific discourse and discovery, as we have chronicled here on the Catalyst. Through the PhRMA-EFPIA Principles for...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates